Europska Unija - norveški - EMA (European Medicines Agency)

abbvie deutschland gmbh co. kg - ombitasvir, paritaprevir, ritonavir - hepatitt c, kronisk - antivirale midler til systemisk bruk - viekirax angis i kombinasjon med andre legemidler for behandling av kronisk hepatitt c (chc) hos voksne. for hepatitt c-virus (hcv) genotypen bestemt aktivitet.

Norveška - norveški - Statens legemiddelverk

bluefish pharmaceuticals ab - diklofenaknatrium - enterotablett - 50 mg

Norveška - norveški - Statens legemiddelverk

bluefish pharmaceuticals ab - diklofenaknatrium - enterotablett - 25 mg

Europska Unija - norveški - EMA (European Medicines Agency)

bristol myers squibb pharma eeig - fedratinib dihydrochloride monohydrate - myeloproliferative disorders; primary myelofibrosis - antineoplastiske midler - inrebic is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis who are janus associated kinase (jak) inhibitor naïve or have been treated with ruxolitinib.

Europska Unija - norveški - EMA (European Medicines Agency)

beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastiske midler - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).

Europska Unija - norveški - EMA (European Medicines Agency)

pfizer europe ma eeig  - abrocitinib - dermatitt, atopisk - andre dermatologiske preparater - cibinqo is indicated for the treatment of moderate-to-severe atopic dermatitis in adults who are candidates for systemic therapy.

Europska Unija - norveški - EMA (European Medicines Agency)

eli lilly nederland b.v. - pirtobrutinib - lymfom, mantelcelle - protein kinase hemmere - treatment of mantle cell lymphoma (mcl).

Norveška - norveški - Statens legemiddelverk

essential pharma (m) limited - karbamazepin - stikkpille - 125 mg

Norveška - norveški - Statens legemiddelverk

essential pharma (m) limited - karbamazepin - stikkpille - 250 mg

Norveška - norveški - Statens legemiddelverk

novartis norge (2) - karbamazepin - tablett - 200 mg